BIOLIGHT Life Sciences

An Israeli public company investing in and managing projects in ophthalmology, including advanced medical devices, medication, diagnostics, and digital healthcare.

Venture Capital Active Ramat Gan, Israel Est. 2005
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages
E Round, C Round, F Round, A Round, D Round, Seed, B Round, G Round, Pre-Seed

About

BioLight Life Sciences Ltd. is an Israeli public company that invests in, develops, manages, and commercializes products in the fields of eye diseases and ocular treatments. The company's portfolio includes advanced medical devices, medication, diagnostics, and digital healthcare solutions, all focused on Israeli innovation in ophthalmology. BioLight aims to identify significant unmet medical needs, assess potential technologies, and connect with a global network of ophthalmic specialists. The company also seeks to create synergies between its portfolio companies. BioLight was incorporated in 2005 and its shares are listed on the Tel Aviv Stock Exchange (TASE: BOLT).

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is BIOLIGHT Life Sciences' primary investment focus?
BIOLIGHT Life Sciences is a publicly-traded company focused on the development and commercialization of companies and products addressing unmet needs and various Ophthalmic conditions, including dry eye syndrome and glaucoma.
Where is BIOLIGHT Life Sciences headquartered?
BIOLIGHT Life Sciences is headquartered in Tel Aviv-Yafo, Israel.
What investment stages does BIOLIGHT Life Sciences participate in?
BIOLIGHT Life Sciences participates in a wide range of investment stages, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
When was BIOLIGHT Life Sciences founded?
BIOLIGHT Life Sciences was founded in 2005.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)